BE2014C063I2 - - Google Patents

Download PDF

Info

Publication number: BE2014C063I2
Authority: BE; Belgium

Application number

BE2014C063C

Other languages

French (fr)

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-04-27

Filing date

2014-10-02

Publication date

2024-08-08

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35242158&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE2014C063(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2014-10-02 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

2024-08-08 Publication of BE2014C063I2 publication Critical patent/BE2014C063I2/fr

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/452—Piperidinium derivatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Indole Compounds (AREA)

BE2014C063C 2004-04-27 2014-10-02 BE2014C063I2 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US56562304P	2004-04-27	2004-04-27

Publications (1)

Publication Number	Publication Date
BE2014C063I2 true BE2014C063I2 (en)	2024-08-08

Family

ID=35242158

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BE2014C063C BE2014C063I2 (en)	2004-04-27	2014-10-02

Country Status (38)

Country	Link
US (9)	US7498440B2 (en)
EP (3)	EP1740177B1 (en)
JP (2)	JP5014121B2 (en)
KR (2)	KR101037026B1 (en)
CN (2)	CN1976701A (en)
AP (1)	AP2213A (en)
AR (1)	AR050902A1 (en)
AU (1)	AU2005237576B2 (en)
BE (1)	BE2014C063I2 (en)
BR (1)	BRPI0510170B8 (en)
CA (2)	CA2755954C (en)
CY (3)	CY1113196T1 (en)
DK (2)	DK2570128T3 (en)
EA (2)	EA021994B1 (en)
EC (1)	ECSP066940A (en)
ES (2)	ES2600405T3 (en)
FR (1)	FR14C0075I2 (en)
HR (2)	HRP20120832T1 (en)
HU (2)	HUE031304T2 (en)
IL (1)	IL178152A (en)
LT (1)	LT2570128T (en)
LU (1)	LU92565I2 (en)
MA (1)	MA28631B1 (en)
MX (1)	MXPA06012405A (en)
MY (1)	MY144753A (en)
NL (1)	NL300694I1 (en)
NO (3)	NO338959B1 (en)
NZ (1)	NZ549997A (en)
PE (1)	PE20060259A1 (en)
PL (2)	PL2570128T3 (en)
PT (2)	PT2570128T (en)
SG (1)	SG186597A1 (en)
SI (2)	SI2570128T1 (en)
TW (1)	TWI363759B (en)
UA (1)	UA95768C2 (en)
UY (1)	UY28871A1 (en)
WO (1)	WO2005104745A2 (en)
ZA (1)	ZA200608565B (en)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW200519108A (en) *	2003-07-17	2005-06-16	Glaxo Group Ltd	Muscarinic acetylcholine receptor antagonists
MXPA06004242A (en) *	2003-10-17	2006-06-28	Glaxo Group Ltd	Muscarinic acetylcholine receptor antagonists field of the invention.
TW200524577A (en) *	2003-11-04	2005-08-01	Glaxo Group Ltd	Muscarinic acetylcholine receptor antagonists
WO2005087236A1 (en) *	2004-03-11	2005-09-22	Glaxo Group Limited	Novel m3 muscarinic acetylcholine receptor antagonists
WO2005095407A1 (en) *	2004-03-17	2005-10-13	Glaxo Group Limited	M3 muscarinic acetylcholine receptor antagonists
WO2005094251A2 (en) *	2004-03-17	2005-10-13	Glaxo Group Limited	M3muscarinic acetylcholine receptor antagonists
US20080194619A1 (en) *	2004-04-05	2008-08-14	Laurent Lecanu	Anti-Hiv Quinuclidine Compounds
AR050902A1 (en)	2004-04-27	2006-12-06	Glaxo Group Ltd	QUINUCLIDINE COMPOSITE, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USOPRATION TO PREPARE SUCH COMPOSITION
EP1747219A4 (en) *	2004-05-13	2010-05-26	Glaxo Group Ltd	Muscarinic acetylcholine receptor antagonists field of the invention
GB0424284D0 (en)	2004-11-02	2004-12-01	Novartis Ag	Organic compounds
JP2008520579A (en) *	2004-11-15	2008-06-19	グラクソグループリミテッド	Novel M3 muscarinic acetylcholine receptor antagonist
EP1937267A4 (en) *	2005-08-02	2009-08-26	Glaxo Group Ltd	M3 muscarinic acetylcholine receptor antagonists
US7767691B2 (en) *	2005-08-18	2010-08-03	Glaxo Group Limited	Muscarinic acetylcholine receptor antagonists containing an azoniabiocyclo[2.2.1] heptane ring system
EA200801997A1 (en)	2006-04-20	2009-04-28	Глаксо Груп Лимитед	NEW CONNECTIONS
GB0611587D0 (en)	2006-06-12	2006-07-19	Glaxo Group Ltd	Novel compounds
NZ574533A (en)	2006-08-01	2011-05-27	Glaxo Group Ltd	Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors
AR065804A1 (en)	2007-03-23	2009-07-01	Smithkline Beecham Corp	COMPOSITE OF INDOL CARBOXAMIDE, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT AND USE OF THIS COMPOUND TO PREPARE A MEDICINAL PRODUCT
CL2009000249A1 (en)	2008-02-06	2009-09-11	Glaxo Group Ltd	Compounds derived from pyrazolo [3,4-b] pyridine-butanediamide; pharmaceutical composition; and its use in the treatment of asthma, chronic obstructive pulmonary disease, rhinitis, atopic dermatitis, psoriasis.
UY31637A1 (en)	2008-02-06	2009-08-03		DUE PHARMACOPHORES-MUSCARINIC ANTAGONISTS OF PDE4
AR070564A1 (en)	2008-02-06	2010-04-21	Glaxo Group Ltd	DERIVATIVES OF 1H-PIRAZOLO [3,4-B] PIRIDIN-5-ILO, PDE4 PHOSPHODIESTERASE INHIBITORS AND ACETILCOLINE MUSCARINIC RECEPTORS (MACHR) ANTAGONISTS, USEFUL IN THE TREATMENT AND / OR PROFILAXES AND PHYSPHOSITIZES, PHYSPHOSYSTEMS, AND PHARMOSES THAT UNDERSTAND THEM
EP2280946B1 (en)	2008-06-05	2016-02-10	Glaxo Group Limited	4-carboxamide indazole derivatives useful as inhibitors of p13-kinases
WO2009147190A1 (en)	2008-06-05	2009-12-10	Glaxo Group Limited	Novel compounds
WO2010094643A1 (en)	2009-02-17	2010-08-26	Glaxo Group Limited	Quinoline derivatives and their uses for rhinitis and urticaria
ES2739352T3 (en)	2009-02-26	2020-01-30	Glaxo Group Ltd	Pharmaceutical formulations comprising 4 - {(1R) -2 - [(6- {2 - [(2,6-dichlorobenzyl) oxy] ethoxy} hexyl) amino] -1-hydroxyethyl} -2- (hydroxymethyl) phenol
US8524751B2 (en)	2009-03-09	2013-09-03	GlaxoSmithKline Intellecutual Property Development	4-oxadiazol-2-YL-indazoles as inhibitors of P13 kinases
US8354539B2 (en)	2009-03-10	2013-01-15	Glaxo Group Limited	Indole derivatives as IKK2 inhibitors
JP2012520845A (en)	2009-03-17	2012-09-10	グラクソグループリミテッド	Pyrimidine derivatives used as Itk inhibitors
RS53830B1 (en)	2009-04-30	2015-06-30	Glaxo Group Limited	INDASOLS SUBSTITUTED BY OXAZOLE AS PI3-KINASE INHIBITORS
WO2011029896A1 (en)	2009-09-11	2011-03-17	Glaxo Group Limited	Methods of preparation of muscarinic acetylcholine receptor antagonists
GB0921075D0 (en)	2009-12-01	2010-01-13	Glaxo Group Ltd	Novel combination of the therapeutic agents
WO2011067365A1 (en)	2009-12-03	2011-06-09	Glaxo Group Limited	Benzpyrazole derivatives as inhibitors of p13 kinases
WO2011067364A1 (en)	2009-12-03	2011-06-09	Glaxo Group Limited	Novel compounds
EP2507231A1 (en)	2009-12-03	2012-10-10	Glaxo Group Limited	Indazole derivatives as pi 3 - kinase inhibitors
ES2655083T3 (en) *	2010-01-28	2018-02-16	Theron Pharmaceuticals, Inc.	Derivatives of 7-azoniabicyclo [2.2.1] heptane, production methods, and pharmaceutical uses of these
WO2011110575A1 (en)	2010-03-11	2011-09-15	Glaxo Group Limited	Derivatives of 2-[2-(benzo- or pyrido-) thiazolylamino]-6-aminopyridine, useful in the treatment of respiratoric, allergic or inflammatory diseases
CA2803418A1 (en) *	2010-06-22	2011-12-29	Chiesi Farmaceutici S.P.A.	Dry powder formulation comprising an antimuscarinic drug
HRP20151017T1 (en)	2010-09-08	2015-10-23	Glaxosmithkline Intellectual Property Development Limited	POLYMORPHS AND SALTS N- [5- [4- (5 - {[(2R, 6S) -2,6-DIMETHYL-4-MORPHOLINYL] METHYL} -1,3-OXAZOL-2-yl) -1H-INDAZZOL- 6-IL] -2- (methyloxy) -3-pyridinyl] methanesulfonamide
WO2012035055A1 (en)	2010-09-17	2012-03-22	Glaxo Group Limited	Novel compounds
GB201018124D0 (en)	2010-10-27	2010-12-08	Glaxo Group Ltd	Polymorphs and salts
AU2012266541A1 (en) *	2011-06-08	2014-01-09	Glaxo Group Limited	Combination comprising umeclidinium and a corticosteroid
WO2012168160A1 (en)	2011-06-08	2012-12-13	Glaxo Group Limited	Dry powder inhaler compositions comprising umeclidinium
KR20140147891A (en)	2012-04-13	2014-12-30	글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드	Aggregate particles
RU2502743C1 (en) *	2012-08-03	2013-12-27	Федеральное государственное бюджетное учреждение "Российский кардиологический научно-производственный комплекс" Министерства здравоохранения и социального развития РФ (ФГБУ "РКНПК" Минздравсоцразвития России)	Synthetic antigen having ability to fix autoantibodies to muscarine m2-receptor
JP6389174B2 (en) *	2012-08-15	2018-09-12	グラクソグループリミテッドＧｌａｘｏＧｒｏｕｐＬｉｍｉｔｅｄ	Chemical method
GB201222679D0 (en) *	2012-12-17	2013-01-30	Glaxo Group Ltd	Pharmaceutical combination products
RU2641285C2 (en) *	2013-07-13	2018-01-17	Бэйцзин Фсвэлкам Текнолоджи Девелопмент Ко., Лтд	Quinine compounds, method for their production and their medical application
HK1225317A1 (en)	2013-07-30	2017-09-08	Glaxosmithkline Intellectual Property Development Limited	Topical compositions for treatment of excessive sweating and methods of use thereof
EP3057588A1 (en)	2013-10-17	2016-08-24	GlaxoSmithKline Intellectual Property Development Limited	Pi3k inhibitor for treatment of respiratory disease
KR20160062179A (en)	2013-10-17	2016-06-01	글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드	Pi3k inhibitor for treatment of respiratory disease
WO2015173701A2 (en)	2014-05-12	2015-11-19	Glaxosmithkline Intellectual Property (No. 2) Limited	Pharmaceutical compositions for treating infectious diseases
US10987363B2 (en)	2014-05-28	2021-04-27	Glaxosmithkline Intellectual Property Development Limited	Fluticasone furoate in the treatment of COPD
EP3215489B1 (en)	2014-11-03	2019-07-24	OLON S.p.A.	Method for the preparation of 1-(2-halogen-ethyl)-4 piperidine-carboxylic acid ethyl esters
KR101613245B1 (en)	2015-04-27	2016-04-18	주식회사 대웅제약	Novel 4-methoxy pyrrole derivatives or salts thereof and pharmaceutical composition comprising the same
CN105461710A (en) *	2015-10-23	2016-04-06	安徽德信佳生物医药有限公司	Preparation method of umeclidinium bromide
MX384539B (en) *	2016-01-08	2025-03-14	Theron Pharmaceuticals Inc	DRY POWDER INHALER COMPOSITIONS OF 7-AZONIABICYCLO[2.2.1]HEPTANE DERIVATIVES
GB201602527D0 (en)	2016-02-12	2016-03-30	Glaxosmithkline Ip Dev Ltd	Chemical compounds
CN107200734B (en) *	2016-03-18	2019-12-24	益方生物科技（上海）有限公司	Quinuclidine derivative and preparation method and application thereof
EP3248970A1 (en)	2016-05-27	2017-11-29	Zentiva K.S.	Forms of umeclidinium bromide
EP3497100A1 (en)	2016-08-08	2019-06-19	GlaxoSmithKline Intellectual Property Development Limited	Chemical compounds
PT109740B (en) *	2016-11-14	2020-07-30	Hovione Farmaciencia Sa	PROCESS FOR THE PREPARATION OF UMECLIDINUM BROMIDE
WO2018163212A1 (en) *	2017-03-08	2018-09-13	Gbr Laboratories Pvt. Ltd	A process for the preparation of umeclidinium bromide and intermediates thereof
GB201706102D0 (en)	2017-04-18	2017-05-31	Glaxosmithkline Ip Dev Ltd	Chemical compounds
IT201700058796A1 (en)	2017-05-30	2018-11-30	Olon Spa	Procedure for the preparation of a new intermediate of synthesis of umeclidinium.
GB201712081D0 (en)	2017-07-27	2017-09-13	Glaxosmithkline Ip Dev Ltd	Chemical compounds
WO2019086463A1 (en)	2017-10-30	2019-05-09	Baxalta GmbH	Environmentally compatible detergents for inactivation of lipid-enveloped viruses
CN108558860B (en) *	2018-06-04	2020-12-25	成都伊诺达博医药科技有限公司	Method for synthesizing umeclidinium bromide
US11484531B2 (en)	2018-08-30	2022-11-01	Theravance Biopharma R&D Ip, Llc	Methods for treating chronic obstructive pulmonary disease
PT115583B (en)	2019-06-17	2022-05-02	Hovione Farm S A	CONTINUOUS PROCESS FOR THE PREPARATION OF ANTICHOLINERGIC DRUGS
CN113387923A (en) *	2020-03-13	2021-09-14	诺华股份有限公司	Pharmaceutical compositions of lipoic acid choline ester salts and methods of treatment using the same
CA3173172A1 (en)	2020-03-26	2021-09-30	Christopher D. Kane	Cathepsin inhibitors for preventing or treating viral infections
CN111484445B (en) *	2020-04-21	2021-05-18	广东莱佛士制药技术有限公司	Method for separating and purifying the intermediate of high-purity umeclidinium bromide
US12358908B2 (en)	2020-04-26	2025-07-15	Beijing Showby Pharmaceutical Co., Ltd.	Crystals, preparation method and application of a muscarinic receptor antagonist
AU2021341508A1 (en)	2020-09-10	2023-05-25	Precirix N.V.	Antibody fragment against fap
CN112479983B (en) *	2020-11-25	2022-07-12	江苏豪森药业集团有限公司	Wumei ammonium bromide intermediate and preparation method thereof
PT117440B (en)	2021-09-03	2024-04-26	Hovione Farm S A	PROCESS FOR THE PREPARATION OF CHLOROAQUIL SUBSTITUTED CYCLIC AMINES
WO2023203135A1 (en)	2022-04-22	2023-10-26	Precirix N.V.	Improved radiolabelled antibody
AU2023264245A1 (en)	2022-05-02	2024-12-19	Precirix N.V.	Pre-targeting
WO2024251812A1 (en)	2023-06-07	2024-12-12	Pharmazell Gmbh	A process for the preparation of umeclidinium bromide intermediate

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2800481A (en) *	1955-07-01	1957-07-23	Smith Kline French Lab	Tertiary alcohol derivatives of 8-alkylnortropanes and the acid and quaternary ammonium salts thereof
US2800478A (en) *	1955-07-01	1957-07-23	Smith Kline French Lab	3-substituted-8-alkylnortropanes and the acid and quaternary ammonium salts thereof
AT298118B (en) *	1967-06-08	1972-04-25	Siemens Ag	Method for converting voltages into digital values and device for carrying out the method
GB1242211A (en)	1967-08-08	1971-08-11	Fisons Pharmaceuticals Ltd	Pharmaceutical composition
GB1230087A (en)	1967-08-17	1971-04-28
GB1381872A (en)	1971-06-22	1975-01-29	Fisons Ltd	Pharmaceutical compositions for inhalation
CY1308A (en)	1979-12-06	1985-12-06	Glaxo Group Ltd	Device for dispensing medicaments
EP0069715B1 (en)	1981-07-08	1986-11-05	Aktiebolaget Draco	Powder inhalator
DK172541B1 (en)	1982-10-08	1998-12-07	Glaxo Group Ltd	Apparatus for administering medications to patients and a drug package for use in the apparatus
GB2169265B (en)	1982-10-08	1987-08-12	Glaxo Group Ltd	Pack for medicament
AU591152B2 (en)	1985-07-30	1989-11-30	Glaxo Group Limited	Devices for administering medicaments to patients
IT1204826B (en)	1986-03-04	1989-03-10	Chiesi Farma Spa	INHALATION PHARMACEUTICAL COMPOSITIONS
GB9004781D0 (en)	1990-03-02	1990-04-25	Glaxo Group Ltd	Device
US5780466A (en) *	1995-01-30	1998-07-14	Sanofi	Substituted heterocyclic compounds method of preparing them and pharmaceutical compositions in which they are present
WO1998024788A1 (en) *	1996-12-02	1998-06-11	Georgetown University	Tropane derivatives and method for their synthesis
US6248752B1 (en) *	1998-02-27	2001-06-19	Charles Duane Smith	Azabicyclooctane compositions and methods for enhancing chemotherapy
US6262066B1 (en) *	1998-07-27	2001-07-17	Schering Corporation	High affinity ligands for nociceptin receptor ORL-1
ES2165768B1 (en)	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
SI1353919T1 (en) *	2000-12-28	2006-12-31	Almirall Prodesfarma Ag	Novel quinuclidine derivatives and medicinal compositions containing the same
RU2004110717A (en) *	2001-10-17	2005-10-20	Юсиби, С.А. (Be)	Quinuclidine derivatives, methods for their preparation and their use as both M2- and / or M3-muscarinic receptors
JP2005510523A (en) *	2001-11-09	2005-04-21	ファルマシアアンドアップジョンカンパニーリミティドライアビリティーカンパニー	Azabicyclic phenyl fused heterocyclic compounds and use of the compounds as α7NACHR ligands
CA2470956C (en) *	2001-12-20	2011-08-02	Laboratorios S.A.L.V.A.T., S.A.	1-alkyl-1-azoniabicyclo[2.2.2]octane carbamate derivatives and their use as muscarinic receptor antagonists
US6696462B2 (en) *	2002-01-31	2004-02-24	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions
ES2206021B1 (en)	2002-04-16	2005-08-01	Almirall Prodesfarma, S.A.	NEW DERIVATIVES OF PIRROLIDINIO.
ES2204295B1 (en) *	2002-07-02	2005-08-01	Almirall Prodesfarma, S.A.	NEW DERIVATIVES OF QUINUCLIDINE-AMIDE.
UY27927A1 (en)	2002-08-06	2003-12-31	Glaxo Group Ltd	ACETILCOLINE M3 MUSCARINIC RECEIVER ANTAGONISTS
WO2004091482A2 (en)	2003-04-07	2004-10-28	Glaxo Group Limited	M3 muscarinic acetylcholine receptor antagonists
PE20050711A1 (en)	2003-07-17	2005-09-10	Glaxo Group Ltd	8-AZONIABICYCLE COMPOUNDS [3.2.1] OCTANS AS ANTAGONISTS OF MUSCARINIC ACETYLCHOLINE RECEPTORS
TW200519108A (en)	2003-07-17	2005-06-16	Glaxo Group Ltd	Muscarinic acetylcholine receptor antagonists
PE20050327A1 (en)	2003-07-17	2005-06-08	Glaxo Group Ltd	DERIVATIVES OF 8-AZONIABICICLO [3.2.1] OCTANE AS ANTAGONISTS OF MUSCARINIC ACETYLCHOLINE RECEPTORS
CN101230061A (en)	2003-10-14	2008-07-30	葛兰素集团有限公司	Muscarinic acetycholine receptor antagonists
MXPA06004242A (en)	2003-10-17	2006-06-28	Glaxo Group Ltd	Muscarinic acetylcholine receptor antagonists field of the invention.
TW200524577A (en)	2003-11-04	2005-08-01	Glaxo Group Ltd	Muscarinic acetylcholine receptor antagonists
ES2329586T3 (en) *	2003-11-21	2009-11-27	Theravance, Inc.	COMPOUNDS THAT HAVE AGONIST ACTIVITY OF THE BETA2 ADRENERGIC RECEIVER AND ANTAGONIST OF THE MUSCARINE RECEIVER.
UY28645A1 (en)	2003-12-03	2005-06-30	Glaxo Group Ltd	NEW ANTAGONISTS OF THE M3 ACETILCOLINE MUSCARINIC RECEPTOR
PE20050861A1 (en)	2003-12-03	2005-12-10	Glaxo Group Ltd	DERIVATIVES OF QUATERNARY AMMONIUM CYCLIC SALTS AS ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR
TW200534855A (en)	2004-01-13	2005-11-01	Glaxo Group Ltd	Muscarinic acetylcholine receptor antagonists
WO2005086873A2 (en)	2004-03-11	2005-09-22	Glaxo Group Limited	Novel m3 muscarinic acetylcholine receptor antagonists
WO2005087236A1 (en)	2004-03-11	2005-09-22	Glaxo Group Limited	Novel m3 muscarinic acetylcholine receptor antagonists
WO2005094251A2 (en)	2004-03-17	2005-10-13	Glaxo Group Limited	M3muscarinic acetylcholine receptor antagonists
WO2005095407A1 (en)	2004-03-17	2005-10-13	Glaxo Group Limited	M3 muscarinic acetylcholine receptor antagonists
US20070185088A1 (en)	2004-03-17	2007-08-09	Jakob Busch-Petersen	M3 muscarinic acetylchoine receptor antagonists
US20070185090A1 (en)	2004-03-17	2007-08-09	Jakob Busch-Petersen	Muscarinic acetylchoine receptor antagonists
WO2005099706A2 (en)	2004-04-07	2005-10-27	Glaxo Group Limited	Muscarinic acetylcholine receptor antagonists
AR050902A1 (en)	2004-04-27	2006-12-06	Glaxo Group Ltd	QUINUCLIDINE COMPOSITE, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USOPRATION TO PREPARE SUCH COMPOSITION
EP1747219A4 (en)	2004-05-13	2010-05-26	Glaxo Group Ltd	Muscarinic acetylcholine receptor antagonists field of the invention
TW200606161A (en)	2004-05-28	2006-02-16	Glaxo Group Ltd	Muscarinic acetylcholine receptor antagonists
WO2006005057A2 (en)	2004-06-30	2006-01-12	Glaxo Group Limited	Muscarinic acetylcholine receptor antagonists
WO2006017768A2 (en)	2004-08-05	2006-02-16	Glaxo Group Limited	Muscarinic acetylcholine receptor antagonists
WO2006017767A2 (en)	2004-08-06	2006-02-16	Glaxo Group Limited	Muscarinic acetylcholine receptor antagonists
JP2008518939A (en)	2004-10-29	2008-06-05	グラクソグループリミテッド	Muscarinic acetylcholine receptor antagonist
WO2006055503A2 (en)	2004-11-15	2006-05-26	Glaxo Group Limited	Novel m3 muscarinic acetylcholine receptor antagonists
JP2008520579A (en)	2004-11-15	2008-06-19	グラクソグループリミテッド	Novel M3 muscarinic acetylcholine receptor antagonist
PE20060826A1 (en)	2004-12-06	2006-10-08	Smithkline Beecham Corp	OLEOPHINIC DERIVATIVE OF 8-AZONIABICICLO [3.2.1] OCTANE AND THE PHARMACEUTICAL COMBINATION THAT INCLUDES IT
PE20061162A1 (en)	2004-12-06	2006-10-14	Smithkline Beecham Corp	COMPOUNDS OLEFINIC DERIVATIVES OF 8-AZONIABICICLO [3.2.1] OCTANES
WO2006065755A2 (en)	2004-12-13	2006-06-22	Glaxo Group Limited	Quaternary ammonium salts of fused hetearomatic amines as novel muscarinic acetylcholine receptor antagonists
WO2006065788A2 (en)	2004-12-13	2006-06-22	Glaxo Group Limited	Novel muscarinic acetylcholine receptor antagonists
WO2007018508A1 (en)	2005-07-28	2007-02-15	Glaxo Group Limited	Novel m3 muscarinic acetycholine receptor antagonists
WO2007018514A1 (en)	2005-07-28	2007-02-15	Glaxo Group Limited	Novel m3 muscarinic acetylcholine receptor antagonists
EP1937267A4 (en)	2005-08-02	2009-08-26	Glaxo Group Ltd	M3 muscarinic acetylcholine receptor antagonists
WO2007016650A2 (en)	2005-08-02	2007-02-08	Glaxo Group Limited	M3 muscarinic acetylcholine receptor antagonists
US7767691B2 (en)	2005-08-18	2010-08-03	Glaxo Group Limited	Muscarinic acetylcholine receptor antagonists containing an azoniabiocyclo[2.2.1] heptane ring system
GB0921075D0 (en) *	2009-12-01	2010-01-13	Glaxo Group Ltd	Novel combination of the therapeutic agents

2005
- 2005-04-25 AR ARP050101627A patent/AR050902A1/en active IP Right Grant
- 2005-04-25 MY MYPI20051806A patent/MY144753A/en unknown
- 2005-04-25 UY UY28871A patent/UY28871A1/en not_active Application Discontinuation
- 2005-04-25 PE PE2005000457A patent/PE20060259A1/en active IP Right Grant
- 2005-04-25 TW TW094113034A patent/TWI363759B/en active
- 2005-04-27 DK DK12170402.7T patent/DK2570128T3/en active
- 2005-04-27 ES ES12170402.7T patent/ES2600405T3/en not_active Expired - Lifetime
- 2005-04-27 ES ES05746609.6T patent/ES2392848T4/en not_active Expired - Lifetime
- 2005-04-27 CN CNA2005800215360A patent/CN1976701A/en active Pending
- 2005-04-27 KR KR1020067022276A patent/KR101037026B1/en not_active Expired - Lifetime
- 2005-04-27 WO PCT/US2005/014386 patent/WO2005104745A2/en not_active Ceased
- 2005-04-27 PL PL12170402T patent/PL2570128T3/en unknown
- 2005-04-27 CA CA2755954A patent/CA2755954C/en not_active Expired - Lifetime
- 2005-04-27 EA EA201100019A patent/EA021994B1/en not_active IP Right Cessation
- 2005-04-27 CA CA2564742A patent/CA2564742C/en not_active Expired - Lifetime
- 2005-04-27 PT PT121704027T patent/PT2570128T/en unknown
- 2005-04-27 UA UAA200611253A patent/UA95768C2/en unknown
- 2005-04-27 LT LTEP12170402.7T patent/LT2570128T/en unknown
- 2005-04-27 EP EP05746609A patent/EP1740177B1/en not_active Expired - Lifetime
- 2005-04-27 AU AU2005237576A patent/AU2005237576B2/en active Active
- 2005-04-27 JP JP2007510915A patent/JP5014121B2/en not_active Expired - Lifetime
- 2005-04-27 BR BRPI0510170A patent/BRPI0510170B8/en not_active IP Right Cessation
- 2005-04-27 HU HUE12170402A patent/HUE031304T2/en unknown
- 2005-04-27 KR KR1020117001909A patent/KR101152032B1/en not_active Expired - Lifetime
- 2005-04-27 SG SG2012087052A patent/SG186597A1/en unknown
- 2005-04-27 US US11/568,330 patent/US7498440B2/en not_active Expired - Lifetime
- 2005-04-27 PT PT05746609T patent/PT1740177E/en unknown
- 2005-04-27 SI SI200532099A patent/SI2570128T1/en unknown
- 2005-04-27 HR HRP20120832TT patent/HRP20120832T1/en unknown
- 2005-04-27 CN CN2010105580787A patent/CN102040602A/en active Pending
- 2005-04-27 EP EP12170402.7A patent/EP2570128B1/en not_active Expired - Lifetime
- 2005-04-27 SI SI200531605T patent/SI1740177T1/en unknown
- 2005-04-27 AP AP2006003746A patent/AP2213A/en active
- 2005-04-27 EA EA200601991A patent/EA015033B1/en not_active IP Right Cessation
- 2005-04-27 EP EP16177012.8A patent/EP3111936A1/en not_active Withdrawn
- 2005-04-27 NZ NZ549997A patent/NZ549997A/en not_active IP Right Cessation
- 2005-04-27 MX MXPA06012405A patent/MXPA06012405A/en active IP Right Grant
- 2005-04-27 DK DK05746609.6T patent/DK1740177T3/en active
- 2005-04-27 PL PL05746609T patent/PL1740177T3/en unknown
2006
- 2006-09-18 IL IL178152A patent/IL178152A/en active Protection Beyond IP Right Term
- 2006-10-13 ZA ZA2006/08565A patent/ZA200608565B/en unknown
- 2006-10-20 EC EC2006006940A patent/ECSP066940A/en unknown
- 2006-10-31 MA MA29426A patent/MA28631B1/en unknown
- 2006-11-24 NO NO20065417A patent/NO338959B1/en active Protection Beyond IP Right Term
2007
- 2007-07-09 US US11/774,867 patent/US7488827B2/en active Active
2009
- 2009-01-14 US US12/353,436 patent/US8183257B2/en not_active Expired - Lifetime
2012
- 2012-02-22 US US13/401,890 patent/US8309572B2/en not_active Expired - Lifetime
- 2012-04-13 JP JP2012092339A patent/JP5398871B2/en not_active Expired - Lifetime
- 2012-09-26 US US13/627,007 patent/US8575347B2/en not_active Expired - Fee Related
- 2012-10-17 CY CY20121100965T patent/CY1113196T1/en unknown
2013
- 2013-10-14 US US14/052,816 patent/US8853404B2/en not_active Expired - Lifetime
2014
- 2014-09-04 US US14/476,940 patent/US9045469B2/en not_active Expired - Lifetime
- 2014-09-26 HU HUS1400053C patent/HUS1400053I1/en unknown
- 2014-10-02 FR FR14C0075C patent/FR14C0075I2/en active Active
- 2014-10-02 BE BE2014C063C patent/BE2014C063I2/fr unknown
- 2014-10-02 NL NL300694C patent/NL300694I1/nl unknown
- 2014-10-02 LU LU92565C patent/LU92565I2/en unknown
- 2014-10-03 CY CY2014043C patent/CY2014043I1/en unknown
2015
- 2015-05-08 US US14/707,543 patent/US9144571B2/en not_active Expired - Lifetime
- 2015-09-10 US US14/849,775 patent/US20160002220A1/en not_active Abandoned
2016
- 2016-10-10 CY CY20161101008T patent/CY1118082T1/en unknown
- 2016-10-25 HR HRP20161385TT patent/HRP20161385T1/en unknown
2017
- 2017-05-04 NO NO2017017C patent/NO2017017I1/en unknown
- 2017-05-04 NO NO2017018C patent/NO2017018I2/en unknown

Also Published As

Publication number	Publication date
AP2006003746A0 (en)	2006-10-31
JP5014121B2 (en)	2012-08-29
EP1740177B1 (en)	2012-08-08
UA95768C2 (en)	2011-09-12
PT1740177E (en)	2012-11-02
US20140371264A1 (en)	2014-12-18
EA021994B1 (en)	2015-10-30
ECSP066940A (en)	2006-12-20
AU2005237576A1 (en)	2005-11-10
UY28871A1 (en)	2005-11-30
EP1740177A4 (en)	2010-05-05
KR101037026B1 (en)	2011-05-25
SI2570128T1 (en)	2016-11-30
SG186597A1 (en)	2013-01-30
US9045469B2 (en)	2015-06-02
US20090124653A1 (en)	2009-05-14
CA2564742C (en)	2012-01-10
PL2570128T3 (en)	2017-09-29
BRPI0510170B8 (en)	2021-05-25
EA201100019A1 (en)	2011-12-30
FR14C0075I2 (en)	2015-05-22
LU92565I9 (en)	2019-01-17
IL178152A0 (en)	2006-12-31
EP3111936A1 (en)	2017-01-04
AP2213A (en)	2011-03-01
FR14C0075I1 (en)	2014-11-21
WO2005104745A3 (en)	2006-08-03
DK1740177T3 (en)	2012-10-29
NL300694I2 (en)	2015-12-29
SI1740177T1 (en)	2012-12-31
CY2014043I2 (en)	2015-12-09
CY1118082T1 (en)	2017-06-28
TW200605887A (en)	2006-02-16
ES2600405T3 (en)	2017-02-08
EA015033B1 (en)	2011-04-29
JP2012162559A (en)	2012-08-30
CN1976701A (en)	2007-06-06
MA28631B1 (en)	2007-06-01
CN102040602A (en)	2011-05-04
WO2005104745A2 (en)	2005-11-10
DK2570128T3 (en)	2016-11-07
ES2392848T3 (en)	2012-12-14
LU92565I2 (en)	2014-12-02
ZA200608565B (en)	2019-12-18
US7498440B2 (en)	2009-03-03
US20160002220A1 (en)	2016-01-07
HRP20120832T1 (en)	2012-11-30
US20070185155A1 (en)	2007-08-09
NZ549997A (en)	2010-10-29
IL178152A (en)	2011-05-31
US20070249664A1 (en)	2007-10-25
US20140080863A1 (en)	2014-03-20
CY1113196T1 (en)	2015-12-09
US8575347B2 (en)	2013-11-05
JP5398871B2 (en)	2014-01-29
PT2570128T (en)	2016-10-07
US20130030015A1 (en)	2013-01-31
LT2570128T (en)	2016-10-10
ES2392848T4 (en)	2014-10-01
NO2017018I2 (en)	2018-05-14
TWI363759B (en)	2012-05-11
US20120157491A1 (en)	2012-06-21
NO2017018I1 (en)	2017-05-04
NO2017017I1 (en)	2017-05-04
NO338959B1 (en)	2016-11-07
US7488827B2 (en)	2009-02-10
CA2755954C (en)	2014-02-18
BRPI0510170A (en)	2007-10-02
US8853404B2 (en)	2014-10-07
CA2755954A1 (en)	2005-11-10
EP1740177A2 (en)	2007-01-10
HRP20161385T1 (en)	2016-12-02
CA2564742A1 (en)	2005-11-10
US9144571B2 (en)	2015-09-29
KR20110010841A (en)	2011-02-07
HK1102423A1 (en)	2007-11-23
HUE031304T2 (en)	2017-07-28
KR20070015412A (en)	2007-02-02
PL1740177T3 (en)	2012-12-31
NL300694I1 (en)	2015-12-29
PE20060259A1 (en)	2006-03-25
NO20065417L (en)	2006-12-29
CY2014043I1 (en)	2015-12-09
US20150238470A1 (en)	2015-08-27
US8183257B2 (en)	2012-05-22
EP2570128B1 (en)	2016-08-10
US8309572B2 (en)	2012-11-13
EP2570128A1 (en)	2013-03-20
HUS1400053I1 (en)	2017-07-28
BRPI0510170B1 (en)	2018-12-18
KR101152032B1 (en)	2012-06-11
JP2007534769A (en)	2007-11-29
AR050902A1 (en)	2006-12-06
MY144753A (en)	2011-10-31
MXPA06012405A (en)	2007-01-17
AU2005237576B2 (en)	2012-01-12
EA200601991A1 (en)	2007-02-27

Publication	Publication Date	Title
BE2020C513I2 (en)	2024-08-08
NL300694I2 (en)	2015-12-29
JP2004332738A5 (en)	2007-06-21
BR122015024347A2 (en)	2006-12-26
BE2016C042I2 (en)	2024-08-08
BE2014C002I2 (en)	2024-08-08
JP2006166641A5 (en)	2008-01-31
JP2005134370A5 (en)	2007-09-13
JP2005231573A5 (en)	2005-12-08
TWI346455B (en)	2011-08-01
JP2005014207A5 (en)	2007-02-15
AU2004203751A1 (en)	2004-11-04
CN300894877S (zh)	2009-03-25	服装（南航空姐立领连衣裙）
CN301067823S (zh)	2009-11-25	促销用装置
CN300859090S (zh)	2008-12-10	促销用装置
CN300764069S (zh)	2008-04-09	便携式媒体播放机
CN300846738S (zh)	2008-11-05	水龙头
ECSDI045450S (en)	2005-08-11
CN3366156S (en)	2004-05-05
CN3363656S (en)	2004-04-21
CN3350325S (en)	2004-01-28
CN3368601S (en)	2004-05-19
CN3366641S (en)	2004-05-05
CN3377649S (en)	2004-07-07
CN3378803S (en)	2004-07-14